Why Is CRISPR Therapeutics Still Seen as a Long-Term Value Play?

Life Science

Faced with Aggression from Medtronic and Johnson & Johnson, How Does Intuitive Surgical Defend Its Monopoly?

Life Science

Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change?

Life Science

FDA’s Wrath Sends ImmunityBio Stock Down Over 3%

Life Science

Premium of 34%! Neurocrine Acquires Soleno Therapeutics in All-Cash Deal 

Life Science

Blackstone Raises $6.3 Billion for Record Breaking Life Sciences Fund

Life Science

These Two Healthcare Dividend Stocks Offer a Safe Haven As Tech Stocks Keep Falling

Life Science

Up to 100%! Trump’s Drug Tariffs Target Overseas Production

Life Science

Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise

Life Science

Lilly Nears $1,000 After Oral Obesity Drug Approval, Fueling Split Talk

Life Science

Two Undervalued Healthcare Stocks Poised for a 60% Upside

Life Science

BridgeBio Secures Attruby Approval, Triggers Price Target Hikes

Life Science

Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage?

Life Science

This Popular ETF Quietly Boosted Its Healthcare Stake – High-Yield Dividend Stocks Are the New Favorite

Life Science

Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms

Life Science